Taiwan
· Delayed Price · Currency is TWD Genomics BioSci & Tech. Co.,Ltd. Statistics
Total Valuation
Genomics BioSci & Tech. Co.,Ltd. has a market cap or net worth of TWD 1.39 billion. The enterprise value is 1.62 billion.
| Market Cap | 1.39B |
| Enterprise Value | 1.62B |
Important Dates
The next estimated earnings date is Tuesday, April 22, 2025.
| Earnings Date | Apr 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Genomics BioSci & Tech. Co.,Ltd. has 72.45 million shares outstanding. The number of shares has increased by 8.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 72.45M |
| Shares Change (YoY) | +8.03% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 3.47% |
| Owned by Institutions (%) | 0.02% |
| Float | 57.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.33 |
| PB Ratio | 1.99 |
| P/TBV Ratio | 2.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.23 |
| EV / Sales | 3.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.63 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.49.
| Current Ratio | 3.09 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -17.82 |
Financial Efficiency
Return on equity (ROE) is -19.45% and return on invested capital (ROIC) is -5.80%.
| Return on Equity (ROE) | -19.45% |
| Return on Assets (ROA) | -5.36% |
| Return on Capital (ROIC) | -5.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.35 |
| Inventory Turnover | 4.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.47% in the last 52 weeks. The beta is 0.18, so Genomics BioSci & Tech. Co.,Ltd.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -7.47% |
| 50-Day Moving Average | 18.08 |
| 200-Day Moving Average | 18.87 |
| Relative Strength Index (RSI) | 65.10 |
| Average Volume (20 Days) | 97,636 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genomics BioSci & Tech. Co.,Ltd. had revenue of TWD 417.04 million and -158.49 million in losses. Loss per share was -2.19.
| Revenue | 417.04M |
| Gross Profit | 116.65M |
| Operating Income | -103.23M |
| Pretax Income | -160.97M |
| Net Income | -158.49M |
| EBITDA | -56.83M |
| EBIT | -103.23M |
| Loss Per Share | -2.19 |
Balance Sheet
The company has 261.42 million in cash and 390.71 million in debt, giving a net cash position of -129.29 million or -1.78 per share.
| Cash & Cash Equivalents | 261.42M |
| Total Debt | 390.71M |
| Net Cash | -129.29M |
| Net Cash Per Share | -1.78 |
| Equity (Book Value) | 799.35M |
| Book Value Per Share | 9.63 |
| Working Capital | 335.77M |
Cash Flow
In the last 12 months, operating cash flow was -79.35 million and capital expenditures -208.66 million, giving a free cash flow of -288.02 million.
| Operating Cash Flow | -79.35M |
| Capital Expenditures | -208.66M |
| Free Cash Flow | -288.02M |
| FCF Per Share | -3.98 |
Margins
Gross margin is 27.97%, with operating and profit margins of -24.75% and -38.00%.
| Gross Margin | 27.97% |
| Operating Margin | -24.75% |
| Pretax Margin | -38.60% |
| Profit Margin | -38.00% |
| EBITDA Margin | -13.63% |
| EBIT Margin | -24.75% |
| FCF Margin | n/a |
Dividends & Yields
Genomics BioSci & Tech. Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.03% |
| Shareholder Yield | -8.03% |
| Earnings Yield | -11.40% |
| FCF Yield | -20.71% |
Stock Splits
The last stock split was on August 8, 2023. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 8, 2023 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Genomics BioSci & Tech. Co.,Ltd. has an Altman Z-Score of 2.19. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.19 |
| Piotroski F-Score | n/a |